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The membrane interaction and solution conformation of two mutants of the h-hairpin antimicrobial peptide, protegrin-1 (PG-1), are
investigated to understand the structural determinants of antimicrobial potency. One mutant, [A6,8,13,15] PG-1, does not have the two disulfide
bonds in wild-type PG-1, while the other, [D4,18 G10] PG-1, has only half the number of cationic residues.
31P solid-state NMR lineshapes of
uniaxially aligned membranes indicate that the membrane disorder induced by the three peptides decreases in the order of PG-1>[D4,18 G10] PG-
1H[A6,8,13,15] PG-1. Solution NMR studies of the two mutant peptides indicate that [D4,18 G10] PG-1 preserves the h-hairpin fold of the wild-type
peptide while [A6,8,13,15] PG-1 adopts a random coil conformation. These NMR results correlate well with the known activities of these peptides.
Thus, for this class of peptides, the presence of a h-hairpin fold is more essential than the number of cationic charges for antimicrobial activity.
This study indicates that 31P NMR lineshapes of uniaxially aligned membranes are well correlated with antimicrobial activity, and can be used as a
diagnostic tool to understand the peptide–lipid interactions of these antimicrobial peptides.
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The peptide–lipid interactions of an increasing number of
antimicrobial peptides have recently been examined using 31P
NMR (for review, see [1,2]). The 31P spectra provide rich
information on the response of lipid bilayers to peptide
binding, which in turn shed light on the mechanism of action
of these peptides. 31P chemical shift anisotropy (CSA) is
sensitive to both the lipid phase and the headgroup conforma-
tion [3]. The 100% natural abundance and the high gyromag-
netic ratio of the 31P spin further make 31P NMR a high-
sensitivity probe of peptide–lipid interactions. While wide-line
31P CSA spectra of unoriented proteoliposomes were com-0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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glycerol; POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine;
DLPC, dilauroylphosphatidylcholine; DMPC, dimyristoylphosphatidylcholine;
DPG, diphosphatidylglycerol
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E-mail address: mhong@iastate.edu (M. Hong).monly measured and analyzed, the signals of non-lamellar
lipids induced by the peptide usually overlap with the powder
pattern of the remaining lamellar bilayer. This spectral overlap
limits the structural information that can be extracted [4–6]. To
resolve multiple lipid morphologies, macroscopically oriented
samples can be prepared for which the 31P signal of each
distinct lipid phase is narrowed to a single anisotropic
frequency. A number of peptides, such as PG-1, RTD-1, LL-
37, and MSI-78 [7–11], have recently been investigated using
this uniaxial alignment approach.
Despite the increasing knowledge of the peptide-induced
changes of membrane morphology and dynamics, it is not clear
whether the observed deviations of the 31P spectral lineshape
from that of the lamellar La phase occur specifically for
membrane-lytic peptides, or whether they are generally true
even for non-membrane disruptive peptides as long as the
peptide concentration is sufficiently high. Another common
underlying assumption in using 31P NMR for understanding
peptide–lipid interaction is that the amount of the non-lamellar
lipid signals correlates with antimicrobial potency. This
assumption remains to be verified. If the membrane disorderta 1716 (2005) 11 – 18
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activity, then one may use 31P NMR as a simple molecular
diagnostic tool of the antimicrobial activities of these peptides.
In addition to establishing a correlation between 31P spectral
disorder and antimicrobial activity, it is important to understand
whether and how the conformation of a peptide, dictated by its
amino acid sequence, affects its membrane disruptive ability.
In this study, we combine 31P solid-state NMR and 1H
solution NMR to examine the membrane-disruptive ability and
the solution conformation of two PG-1 derivatives, and relate
these to the known antimicrobial activities of these peptides.
Protegrin-1 (PG-1) is a h-hairpin peptide with potent and
broad-spectrum antimicrobial activities [12,13]. It contains six
Arg residues distributed at the two ends of the hairpin, and is
stabilized by two cross-strand disulfide bonds. Two PG-1
mutants are studied here. [A6,8,13,15] PG-1 replaces all four Cys
residues with Ala, while [D4,18 G10] PG-1 reduces the number
of cationic residues from six to three compared to the wild-type
peptide (Fig. 1). The activities of these two mutants have been
measured before and found to be more than an order of
magnitude weaker than wild type PG-1 [14]. We show here that
there is indeed a correlation among membrane disorder, the
peptide conformation, and the antimicrobial activity. The least
structured peptide causes the weakest membrane disruption and
is also the one with the lowest antimicrobial activity.
2. Materials and methods
2.1. Materials
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL) and
used without further purification. PG-1 (NH2-RGGRLCYCRRRFCVCVGR-
CONH2), [A6,8,13,15] PG-1 and [D4,18 G10] PG-1 were synthesized using Fmoc
solid-phase peptide synthesis protocols as described previously [7]. In
[A6,8,13,15] PG-1 (NH2-RGGRLAYARRRFAVAVGR-CONH2), the four Cys
residues are replaced by Ala. In [D4,18 G10] PG-1 (NH2-RGGLCYCRGRF-
CVCVG-CONH2), two Arg residues at the N- and C-termini are deleted and
Arg10 at the hairpin tip is replaced by a Gly (Fig. 1).
2.2. Sample preparation
Glass-plate oriented membranes were prepared using a naphthalene-
incorporated procedure [15]. The peptide was dissolved in TFE and mixed
with a chloroform solution of the desired lipids. The mixture was dried under a
stream of N2 gas and the dried film was redissolved in a 2:1 mixture of
chloroform/TFE containing a five-fold excess of naphthalene with respect to
the lipids. The solution was deposited on glass plates (Marienfeld Laboratory
Glassware) of ¨80 Am thickness and 612 mm2 size at a concentration of
0.01–0.02 mg/mm2. The sample was air-dried for 2 h and then vacuum dried
for 5 h to remove all the solvents and naphthalene. The dried membranes were
hydrated first by direct deposition of ¨1 AL of water per plate and then at 95%
relative humidity over a saturated solution of Na2HPO4 for 2–3 days. All
samples were hydrated at room temperature except DMPC, which was hydratedFig. 1. Amino acid sequence of wild-type PG-1 and its two derivatives,
[A6,8,13,15] PG-1 and [D4,18 G10] PG-1.at 30 -C. Subsequently, the glass plates were stacked, wrapped in parafilm and
sealed in a polyethylene bag to prevent dehydration. To ensure reproducibility,
most membrane sample series as a function of peptide concentration were
repeated 2–3 times. The orientational disorder reported below is the average of
these multiple runs.
Solution NMR samples were prepared by dissolving the peptides in a 5-mM
sodium phosphate buffer in 9/1 H2O/D2O at pH 6.5. The peptide concentrations
were ¨3 mM.
2.3. NMR spectroscopy
Static solid-state 31P experiments on oriented peptide– lipid mixtures were
carried out on a Bruker DSX-400 spectrometer operating at a resonance
frequency of 162.12 MHz for 31P and 400.49 MHz for 1H. A double-resonance
probe equipped with a custom-designed rectangular coil with the dimensions of
6125 mm was used. The samples were inserted into the magnet with the
alignment axis parallel to the external magnetic field. The 31P chemical shift
was referenced externally to 85% phosphoric acid at 0 ppm. The experiments
used a 31P 90- excitation pulse of 5 As, a 1H decoupling field strength of ¨50
kHz, and a recycle delay of 2 s. All 31P spectra were processed with a LB of
10 and a GB of 0.05.
All 1H solution spectra were recorded on a Bruker DRX-500 spectrometer
operating at a 1H frequency of 499.867 MHz. TOCSY, NOESY and COSY
spectra were acquired using standard protocols [16]. The 1H chemical shift was
externally referenced to DSS. Solvent suppression was achieved using the
WATERGATE method [17]. Mixing times were 100 ms for TOCSYand 300 ms
for NOESY. For the TOCSY experiment, the spin-lock field strength was 6.5
kHz and the DIPSI-2 [18] sequence was used for isotropic mixing.
3. Results
3.1. 31P NMR of uniaxially aligned lipid membranes
We first compare the orientational disorder of anionic lipid
bilayers induced by the wild type PG-1 and its two mutants.
Previous NMR studies of PG-1 and RTD-1 [8,19] found that
these peptides preferentially disrupt anionic membranes while
creating reduced disorder in neutral or cholesterol-containing
membranes. Thus, anionic lipid bilayers provide a suitable
matrix for testing the membrane-disruptive ability of the PG-1
derivatives. We use POPC/POPG bilayers at a 3:1 molar ratio
as our first model membrane, as it provides a direct
comparison with neutral POPC bilayers and its membrane-
surface charge density is analogous to that of bacterial
membranes [20]. Fig. 2 shows one representative set of 31P
spectra of POPC/POPG bilayers with 0–8 mol% of PG-1,
[D4,18 G10] PG-1, and [A6,8,13,15] PG-1. In the absence of the
peptides, the lipid bilayers give rise to a narrow and partially
resolved peak at 30.8 ppm, which corresponds to the parallel
orientation of the bilayer normal from the magnetic field. The
partial resolution in some of the 0% spectra (top row) reflects
the slightly different 31P chemical shift anisotropies of POPC
and POPG lipids. For the reference PG-1-containing lipids (a),
an isotropic peak at 1.5 ppm grew with increasing concentra-
tion of PG-1, indicating the formation of micelles or small
lipid vesicles upon PG-1 binding [19]. In comparison, the
membranes containing [D4,18 G10] PG-1 showed mild disorder
up to 4% concentration (b). Only when the peptide concen-
tration increased to 8% did a broad peak between 15 ppm
and +20 ppm become significant. In contrast, [A6,8,13,15] PG-1
causes much less membrane disorder at all concentrations used
Fig. 3. 31P spectra of oriented POPE/POPG (3:1) membranes in the presence of
(a) PG-1, (b) [D4,18 G10] PG-1, and (c) [A6,8,13,15] PG-1. The peptide
concentrations are 0%, 2%, 4% and 8% from top to bottom. The spectra were
recorded at 303 K. The fractional disorder of the most concentrated sample in
each series is indicated. The two mutants show similar disorder at 8%
concentration.
Fig. 2. 31P spectra of oriented POPC/POPG (3:1) bilayers with varying concentrations of (a) PG-1, (b) [D4,18 G10] PG-1, and (c) [A6,8,13,15] PG-1. The peptide molar
concentrations are 0%, 2%, 4% and 8% from top to bottom. The fractional disorder is indicated for the highest concentration in each series. Column (a) is reproduced
from Ref. [19].
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the 0- peak, which reflects an increased mosaic spread of the
lipid bilayers [21]. For example, the 0- peak in the 4%
[A6,8,13,15] PG-1 spectrum corresponds to a mosaic spread of
12-. To compare the membrane disorder more quantitatively,
we define fractional disorder as the relative intensity of the
spectral region outside the 0--peak to the total spectral
intensity. Averaged over several repeat samples, we found
that PG-1 causes 74% fractional disorder at 4% peptide
concentration, while [D4,18 G10] PG-1 reaches a similar level
of disorder (70%) only at 8% peptide concentration, and
[A6,8,13,15] PG-1 has the lowest fractional disorder, ¨45%,
even at 8%.
We next examine the effects of the three peptides on POPE/
POPG (3:1) bilayers, which mimic the membrane composition
of bacteria more closely [20]. Fig. 3 shows oriented 31P spectra
of POPE/POPG bilayers in the presence of the peptides. PG-1
shows similar membrane disruptive behavior as towards
POPC/POPG bilayers. However, the isotropic peak, at ¨3.8
ppm, is no longer well resolved from the rest of the powder
intensity (a, bottom). This indicates that the tumbling of the
micelles or vesicles caused by PG-1 is slower, which suggests
that the POPE/POPG vesicles are larger than the POPC/POPG
ones. Similarly, both PG-1 mutants caused reduced membrane
disorder (Fig. 3b, c) than towards POPC/POPG bilayers, as
indicated by the fractional disorder. There is no significant
difference in the membrane disorder between the two mutants
towards the POPE/POPG bilayers.
The possibility that the disorder seen in the POPE/POPG
spectrum containing 4% PG-1 (Fig. 3a) may result from
hexagonal phase lipids can be reasonably ruled out, since the
hexagonal phase has an anisotropy half that of the lamellar
bilayer phase, and thus would have a 90- frequency of 8.5 ppmand a 0- frequency of 11 ppm. No distinct peaks are observed
at these frequencies in the spectra.
To determine how the two PG-1 derivatives interact with
more physiological membranes, we measured the 31P spectra of
oriented E. coli lipid extract, which consists of 57.5% PE,
15.1% PG, 9.8% cardiolipin (or DPG) and 17.6% other lipids
by weight (Avanti Polar Lipids). The 31P lineshapes of the two
mutants (Fig. 4b, c) confirm their different membrane rupturing
Fig. 4. 31P spectra of oriented E. coli lipids in the presence of 4% (a) PG-1, (b)
[D4,18 G10] PG-1, and (c) [A6,8,13,15] PG-1.
Fig. 5. 31P spectra of oriented phosphocholine bilayers with varying acyl chain
lengths in the presence of 4% [D4,18 G10] PG-1 (a–c) and 4% [A6,8,13,15] PG-1
(d– f). The lipids used are: (a, d) DLPC at 295 K; (b, e) DMPC at 303 K; (c, f
POPC at 295 K.
R. Mani et al. / Biochimica et Biophysica Acta 1716 (2005) 11–1814abilities seen in model anionic membranes: the deletion mutant
causes more severe disorder than the Ala mutant. In fact, the
amount of disorder induced by [D4,18 G10] PG-1 is comparable
to that of wild-type PG-1 (Fig. 4a). Similar to the model
membrane results, the type of disorder also differs. [D4,18 G10]
PG-1 creates significant powder intensities between 15 and
15 ppm and has enhanced intensities at the isotropic
frequency, indicative of the onset of an isotropic phase. The
Ala mutant merely broadens the 0- peak asymmetrically,
indicating a larger mosaic spread of the oriented membrane.
The fact that [D4,18 G10] PG-1 causes larger disorder to the E.
coli lipid membrane than to POPE/POPG membranes indicates
that stronger electrostatic association facilitates antimicrobial
activity since the E. coli lipid extracts have a higher anionic
charge density than the model membranes used here.
We can gain further insight into the mode of binding of these
PG-1 mutants to lipid bilayers by examining the membrane-
thickness dependence of the 31P spectra. Fig. 5 shows the spectra
of DLPC (12:0), DMPC (14:0) and POPC (16:0,18:1) bilayers
containing 4% of the two PG-1 mutants. [D4,18 G10] PG-1 shows
increasing disorder with the lipid chain length (a–c), whereas
[A6,8,13,15] PG-1 does not exhibit any dependence on the
membrane thickness and only causes minor orientational
disorder (d–f). These suggest that [D4,18 G10] PG-1, similar to
PG-1 [7], has a tendency to insert into the lipid bilayer as long as
the hydrophobic length of the peptide and the lipid bilayer are
compatible. The wild-type PG-1 has a backbone length of ¨30
A˚ [22]. Combined with the hydrophobic length of the Arg
sidechains at the two ends of the molecule, the wild-type PG-1 is
able to span the DLPC bilayer without causing orientational
defects [7]. This was directly shown by our paramagnetic
relaxation study of PG-1 in Mn2+-bound DLPC bilayers [23].
The deletion mutant, which should be shorter than PG-1 by lessthan ¨4 A˚, should be able to span the same DLPC bilayer. But
compared to the 45 A˚ thick POPC bilayer, the mismatch is
significant enough that the deletion mutant may not be able to
insert into the membrane well. Thus, as the bilayer thickness
increases, membrane defects form, manifesting themselves as
the increased disorder in the 31P spectra.
In contrast, the complete absence of membrane-thickness-
dependence of [A6,8,13,15] PG-1 suggests that [A6,8,13,15] PG-1
binds to the surface of the PC bilayers. The broadened 0- peak
in the DMPC spectrum (e) may result from the higher phase
transition temperature (23 -C) of this lipid, which may change
the slow motion or T2 relaxation time of the lipid membrane in
the presence of the peptide.
3.2. 1H NMR of peptides in solution
The 31P solid-state NMR results above show that the two
PG-1 derivatives cause different degrees as well as types of
disorder to the lipid bilayers from each other and from the wild-
type PG-1. The question then arises as to whether and how the
changes in the amino acid sequence and possible changes in
peptide conformation bring about this difference in the
membrane rupturing abilities. To address this question, we
carried out 1H solution NMR experiments on the two mutants
and compared their backbone conformation and overall three-
dimensional fold with the known structure of PG-1 [24].
Fig. 6 shows the 2D TOCSY spectra of [D4,18 G10] PG-1
and [A6,8,13,15] PG-1. Significantly different chemical shifts are
found, and the deletion mutant exhibits larger shift dispersion
than the Ala mutant. Resonance assignment of the amino acid
residues was carried out using standard protocols [16].
Sequence-specific assignment was obtained for both peptides
due to the presence of sequential connectivities in the 2D
NOESY spectra (Fig. 8).)
Fig. 6. 2D 1H TOCSY spectra of (a) [D4,18 G10] PG-1 and (b) [A6,8,13,15] PG-1. Mixing time: 100 ms.
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two PG-1 mutants, obtained as the difference of the experi-
mental 1H chemical shifts from the random coil values [25].
For both HN and Ha, positive secondary shifts indicate a h-
sheet conformation while negative secondary shifts indicate an
a-helical structure [26]. It can be seen that [A6,8,13,15] PG-1Fig. 7. Differences of HN and Ha chemical shifts from the randomexhibits relatively small secondary shifts, indicating the lack of
a well defined secondary structure, while [D4,18 G10] PG-1
shows a clear h-sheet conformation.
NOESY spectra allow the determination of the three-
dimensional fold of the two mutant peptides. If the hairpin
fold is present, then cross-strand correlation peaks arecoil values for (a) [D4,18 G10] PG-1, and (b) [A6,8,13,15] PG-1.
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both sequential aN (i, i+1) cross peaks that are characteristic
of the h-strand conformation, and cross-strand correlation
peaks, including 7/13, 1/15, 3/13 and 6/13 (a). The observed
cross-strand connectivities for [D4,18 G10] PG-1 are summa-
rized in Fig. 8c. We conclude that [D4,18 G10] PG-1 adopts a
well-defined h-hairpin fold similar to wild-type PG-1. In
contrast, the NOESY spectrum of [A6,8,13,15] PG-1 (b) shows
no cross-strand correlation peaks but only sequential cross
peaks, indicating the lack of a hairpin fold. A COSY
experiment on [A6,8,13,15] PG-1 indicates that the
3JHNa values
of most residues range from 6.8 Hz to 8.3 Hz, whereas the
3JHNa values for the wild-type PG-1 range from 9 Hz to 14 Hz
(not shown). These further confirm the lack of a h-strand
conformation in [A6,8,13,15] PG-1.
4. Discussion
The 31P solid-state NMR and 1H solution NMR results
shown above indicate that the h-hairpin fold is essential for
inducing membrane disorder while the reduction in the number
of positive charges do not affect the membrane disruptive
ability of the peptide significantly. The wild-type PG-1, which
possesses both features, inflicts the most severe disorder to
anionic membranes [19]. Removing the two disulfide bonds, in
[A6,8,13,15] PG-1, nearly abolished the membrane-disruptive
activity. This is manifested as reduced powder intensities in the
31P spectra of aligned membranes containing [A6,8,13,15] PG-1.
The main effect of [A6,8,13,15] PG-1 appears to be the increaseFig. 8. (a) 2D NOESY spectrum of [D4,18 G10] PG-1 with a mixing time of 300 ms. C
with a mixing time of 300 ms. (c) Schematic representation of [D4,18 G10] PG-1, inin the mosaic spread of the aligned membrane, broadening the
0- peak (Figs. 2, 3). This is distinct from the lineshape changes
observed for other antimicrobial peptides with strong activities
such as RTD-1 and PG-1, where significant non 0--peak
intensities are observed and can be attributed to distinct lipid
morphologies such as micelles and lipid tubules [8,19]. In
comparison, reducing the number of Arg residues from six to
three attenuated the membrane disorder but did not remove it.
Thus, maintaining the h-hairpin fold is more important than
retaining the same number of positive charge as that of the
wild-type peptide.
The importance of the h-hairpin fold is consistent with the
view that electrostatic association is only the first step in the
action of cationic antimicrobial peptides. While the anionic
lipopolysaccharides in the outer membrane of Gram-negative
bacteria and the anionic DPG and PG lipids in Gram-positive
bacteria assist peptide binding, ultimately, membrane disrup-
tion requires the bound peptide to adopt the correct conforma-
tion to enable it to insert into the membrane.
The requirement for the h-hairpin fold seen in these PG-1
derivatives has also been observed in tachyplesin, a horseshoe-
crab derived antimicrobial peptide with similar conformation
and charge distribution to PG-1 [27]. A solution NMR study
of tachyplesin variants was recently carried out in which Cys
residues were systematically replaced by Tyr, Phe or Ala [28].
The study found that the Ala mutant is unstructured in
aqueous solution while the Tyr and Phe mutants retain the h-
hairpin structure. By varying the solvents, the authors found
that the retention of the structure by the Tyr and Phe mutantsross-strand NOE peaks are boxed. (b) 2D NOESY spectrum of [A6,8,13,15] PG-1
which the observed non-sequential NOEs are drawn.
Fig. 9. Models of the different interactions between PG-1 mutants and anionic lipid bilayers. (a) [D4,18 G10] PG-1 has a well defined h-hairpin conformation, disrupts
the lamellar structure of the lipid membrane, and likely inserts into the bilayer. (b) [A6,8,13,15] PG-1 has a random coil conformation in solution, does not cause
significant membrane disorder, and likely binds to the surface of the membrane.
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the Ala mutant has the weakest antimicrobial activity, whereas
the Tyr and Phe mutants have strong antimicrobial activities
against a number of Gram-positive and Gram-negative
bacteria [29].
The 1H solution NMR results of the PG-1 derivatives
confirm the design hypothesis that the removal of the
disulfide bridges and the lack of any other compensatory
interactions result in a random coil peptide in solution [14],
whereas the charge-reduced but disulfide-bridged mutant
retains its h-strand backbone conformation and the hairpin
fold. In SDS micelles and E. Coli mimicking lipids,
[A6,8,13,15] PG-1 was found to adopt an a-helical conforma-
tion by CD [30]. Given the weak activity as well as the weak
disorder created by [A6,8,13,15] PG-1 to the lipid bilayer, this
further underscores the importance of the h-hairpin fold for
maintaining the membrane–lytic activity of this class of
peptide sequences.
The relative membrane disorder induced by the three PG-1
peptides observed in the 31P spectra correlates well with the
measured antimicrobial activities. Normalized to that of PG-1,
the minimum inhibitory concentration (MIC) of [A6,8,13,15] PG-
1 is over 64 fold higher against the Gram-negative bacteria P.
aeruginosa and more than 16 times higher against the Gram-
positive bacteria Staphylococcus aureus [14]. The corres-
ponding normalized MIC’s for [D4,18 G10] PG-1 is >32- and
>16-fold that of PG-1. Thus, peptides with stronger antimicro-
bial activities give rise to larger membrane disorder. The 31P-
NMR detected membrane-disruptive ability, the 1H-NMR de-
tected h-hairpin structure, and the antimicrobial activities, all
decrease in the order of PG-1> [D4,18 G10] PG-1H[A6,8,13,15]
PG-1.
The two disulfide-stabilized peptides, PG-1 and [D4,18 G10]
PG-1, exert less disorder towards POPE/POPG bilayers than
towards POPC/POPG bilayers, while the linear analog
[A6,8,13,15] PG-1 shows no such selectivity. The former
suggests that the induction of positive membrane curvature is
one mechanism of action of the active protegrins. The only
difference between POPC and POPE is that POPE has a
smaller headgroup. Thus, POPE can better counter any positive
curvature induced by the peptides as they bind to the
membrane surface, and thus better maintain the lamellar
structure of the bilayer. This positive-curvature mechanism
for membrane disruption has also been observed in other
peptides such as MSI-78 [10], LL-37 [9] and RTD-1 [8]. Thefact that [A6,8,13,15] PG-1 does not show such difference is
simply a reflection of its generally weaker membrane affinity
and disruptive ability.
Fig. 9 gives a schematic representation of our current
understanding of the relation between PG-1 mutant conforma-
tion and peptide–lipid interaction. The deletion mutant has a h-
hairpin structure and efficiently disrupts the membrane
structure. It likely achieves this by inserting into the lipid
bilayer and creating pores. The Ala mutant, on the other hand,
has a random coil conformation in solution and largely retains
the membrane integrity. Its lack of membrane-lytic effects may
result from a surface-bound location, which is suggested by its
lack of dependence on the membrane thickness. The detailed
structure of [D4,18 G10] PG-1 is not known. For example, how
the charged Arg residues are accommodated in the lipid bilayer
and the orientation of the hairpin with respect to the lipid
chains await further studies. Based on our study of wild-type
PG-1, we speculate that [D4,18 G10] PG-1 is oligomerized in the
membrane [31].
In summary, the results shown here indicate that a
correlation indeed exists between the membrane-disruptive
ability of a peptide, detected through 31P spectra, and its
antimicrobial activity, thus validating the use of 31P NMR of
uniaxially aligned membranes for understanding the mecha-
nism of action of antimicrobial peptides. Moreover, the
membrane-disruptive ability is related to the conformation of
the peptide: for protegrins, a strong h-hairpin fold is correlated
with potent membrane disruption. Between the two structural
features examined, charge and h-sheet conformation, the
number of charges is a secondary factor that regulates the
strength of the interaction between the anionic membrane and
the cationic peptide. The more important structure requirement
for antimicrobial activity in this class of peptide sequences is
the h-hairpin fold. As investigated previously through exten-
sive sequence mutations [27,32], the importance of the h-
hairpin fold may result from the fact that it places the
hydrophobic and charged residues in these peptides in an
amphipathic fashion, in order to promote the insertion of the
peptides into the lipid bilayers.
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